Funding This work was supported by the Postdoctoral Innovation Practice Base of the First Affiliated Hospital of Nanchang University (grant 338937), the Jiangxi Provincial Young Talents Project (grant 20204BCJ23016), the National Natural Science Foundation of China (grants 82202869, 82260491, 82160459, 82160469,82360584), the Jiangxi Province Double Thousand Program (grant jxsq2023201108), Key Projects of Jiangxi Province (grant 20232ACB206044), the Science and Technology Department of Jiangxi Province (grant 20202BABL216050), and the Jiangxi Provincial Natural Science Foundation (grant 20232BAB216087 and 20224BAB216008)
Nausea, vomiting, dyspepsia, or abdominal distension in those taking GLP-1 agonists predict increased residual gastric contents
1 patient was diagnosed with paracentral acute middle maculopathy , a condition affecting the central retina
The Science Behind BPC-157 Wound Healing BPC-157 for Different Wound Types BPC-157 and Burns: What the Research Shows How BPC-157 May Reduce Scar Formation BPC-157 for Diabetic and Chronic Wounds Injectable BPC-157 Protocols for Skin Healing Dosage Guidelines and Administration Reconstitution and Storage Timeline and What to Expect Combining BPC-157 with Other Treatments Safety Profile and Considerations Sourcing Quality BPC-157 in Canada Frequently Asked Questions Glossary of Terms References What is BPC-157 and Why Does It Work for Skin Healing
Cureus Journal of Medical Science Please note that by doing so you agree to be added to our monthly email newsletter distribution list
